Prognostic significance of miRNA‐1 (miR‐1) expression in patients with chordoma
Zhenfeng Duan(University of Miami), Francis J. Hornicek(University of Miami), Edwin Choy(Massachusetts General Hospital), Pei Yang(Capital Medical University), Dimitrios Spentzos(Beth Israel Deaconess Medical Center), G. Petur Nielsen(Harvard University), Yu Zhang(Wannan Medical College), Xiaoqian Yang(Shanghai Jiao Tong University), Gregory M. Coté(Harvard University), Jacson Shen(Massachusetts General Hospital), David C. Harmon(Massachusetts General Hospital), Henry J. Mankin(Harvard University), Eiji Osaka(Massachusetts General Hospital)
Cited by 47
Related Papers
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
|The Lancet|2016|766
Gene Expression Profile of <i>BRCA</i>ness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer
|Journal of Clinical Oncology|2010|488
Clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2020|482
Aneurysmal Bone Cyst: A Review of 150 Patients
|Journal of Clinical Oncology|2005|459
A spatially and temporally restricted mouse model of soft tissue sarcoma
|Nature Medicine|2007|305